Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELETRIPTAN HYDROBROMIDE vs ELTROMBOPAG OLAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELETRIPTAN HYDROBROMIDE vs ELTROMBOPAG OLAMINE: Safety Overview

Metric ELETRIPTAN HYDROBROMIDE ELTROMBOPAG OLAMINE
Total FAERS Reports 2,158 16,074
Deaths Reported 12 3,457
Death Rate 0.6% 21.5%
Hospitalizations 271 3,284
Average Patient Age 52.6 yrs 56.5 yrs
% Female Patients 86.2% 57.7%
FDA Approval Date Aug 11, 2017 Apr 18, 2024
Manufacturer Zydus Pharmaceuticals USA Inc. XLCare Pharmaceuticals Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription